The Cigna Group (NYSE:CI) Shares Acquired by Roffman Miller Associates Inc. PA

Roffman Miller Associates Inc. PA lifted its stake in shares of The Cigna Group (NYSE:CI) by 15.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 52,432 shares of the health services provider’s stock after purchasing an additional 7,066 shares during the quarter. Roffman Miller Associates Inc. PA’s holdings in The Cigna Group were worth $14,479,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in CI. Collier Financial bought a new stake in shares of The Cigna Group during the 4th quarter worth $32,000. ORG Wealth Partners LLC bought a new stake in shares of The Cigna Group during the 4th quarter worth $34,000. Prospera Private Wealth LLC bought a new stake in shares of The Cigna Group during the 3rd quarter worth $37,000. Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group during the 4th quarter worth $37,000. Finally, Harbor Capital Advisors Inc. bought a new stake in shares of The Cigna Group during the 3rd quarter worth $45,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CI has been the subject of several recent analyst reports. UBS Group decreased their target price on The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. StockNews.com upgraded The Cigna Group from a “hold” rating to a “buy” rating in a report on Wednesday, February 19th. Raymond James restated a “strong-buy” rating and set a $360.00 target price (down from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. Truist Financial cut their target price on The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a report on Tuesday, February 4th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $372.31.

The Cigna Group Stock Up 0.1 %

Shares of CI stock opened at $299.92 on Monday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The firm’s 50-day moving average is $286.35 and its 200-day moving average is $319.47. The stock has a market cap of $83.42 billion, a price-to-earnings ratio of 24.50, a PEG ratio of 0.98 and a beta of 0.54. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83.

The Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the prior year, the firm earned $6.79 earnings per share. Sell-side analysts predict that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date is Wednesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio is presently 49.35%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.